Using several sources the Altarum Institute’s Center for Sustainable Health Spending produces regular reports analyzing trends in national health spending, including by its components of utilization and prices. The June Health Trend Report gives us a sense of what is happening so far in 2018. (Altarum Report) According to the report, US health spending rose by 4.8% in the first quarter of 2018, compared to the 1st quarter of 2017. That is a slight increase from the growth rates reported for similar periods in 2017 and 2016. Spending on health care services, which is over 70% of total health expenditures (which also covered administrative costs, research, public health spending, etc.), rose by 4.5% in Q1 2018. Prescription drug costs, which have been a volatile, but growing part of total health spending, rose by 3.9% in the first quarter, a lower growth rate than in recent periods. The utilization component of health spending grew by 2.3%, which also is a lower increase than the last few years, and may be linked to declines in coverage. Health prices, on the other hand, have shown an increasing trend, up 2.3% and now accounting for half the total rise in health spending. The number of jobs added in the health care sector, which can reflect demand for services and is linked to health spending, was consistent with prior quarters, at around 80,000. When utilization rises faster than jobs, it suggests some productivity gains, which is as important for health care as for any other industry, perhaps more important as health care is so labor intensive. As the economy continues to be strong, possibly even strengthening, we should be alert for signs that health spending increases, which never seem to come down to the rate of economic growth, are accelerating. Price is a particular concern and early 2018 suggests some greater upward movement in that component. It should be a high priority national goal to get health spending below the rate of economic growth and keep it there. That can be done, but would require some pain for particular companies, like the drug industry and massive health systems, both of which are largely responsible for excessive spending.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Mental health company Headway makes, well, headway, by raising an impressive $125 million round of new capital. The company connects patients with mental health providers and facilitates providers working with...
October 11, 2023
Two health care firms owned by private equity firms are merging in a transaction supposedly valued at $3 billion. HealthComp administers self-funded plans for employers and other groups and Virgin...
September 27, 2023
NextGen, an electronic medical records firm, is being put out of its public company misery, as a PE firm will pay $1.6 billion for the one-time high-flier.
September 7, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace